This study presents a novel ruthenium‐catalyzed method for the regioselective ortho ‐sulphonamidation of benzo b 1,4oxazin‐2‐ones. Utilizing sulfonyl azides, which release benign nitrogen gas as a byproduct, this approach achieves high yields and excellent ortho ‐selectivity in CH functionalization. The protocol exhibits a broad substrate scope, good functional group tolerance, and operational simplicity. Optimization studies and control experiments support a plausible reaction mechanism involving a ruthenium‐metallacycle intermediate. Gram‐scale synthesis demonstrates the practicality and potential of the method to access biologically relevant molecules, significantly expanding CH functionalization in heterocyclic chemistry.
Chaudhary et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: